When evaluating professional-grade skincare, most people focus on the active ingredient list. The delivery format is equally important and far less discussed.
Encapsulation is a formulation technology that wraps an active ingredient in a protective shell. That shell serves several functions. It protects the active from degradation by light, air, and pH changes during storage. It controls when and how the active is released into the skin. And it allows higher doses to be used without the surface irritation that high-concentration unencapsulated actives can produce.
The practical difference is most visible with vitamin A. Conventional retinol is released immediately on skin contact. At 1%, this produces the irritation and peeling many people associate with vitamin A products. Encapsulated retinaldehyde at 1% releases slowly across 8 to 12 hours. The skin receives a continuous low-level supply rather than a single concentrated dose. The result is that 1% encapsulated vitamin A can be used twice daily without the adjustment period conventional retinol requires.
Retinaldehyde also has a shorter conversion pathway. Retinol requires two enzymatic steps to reach retinoic acid, the biologically active form. Retinaldehyde requires only one. This means encapsulated retinaldehyde works closer to prescription strength while remaining accessible for twice-daily use.
The same logic applies to vitamin B3. At 10%, encapsulated vitamin B3 delivers a dose with a substantial evidence base for skin tone and barrier support. Many retail products contain 2% or less of the same ingredient. Both can list vitamin B3 on the label. The clinical difference between those two concentrations is meaningful.
Rejuvaus built its range around this principle. The Repair and Refine ABC Serum contains 33 actives including 1% encapsulated vitamin A, 10% encapsulated vitamin B3, and 5% vitamin C superfruit extract, all within a single twice-daily formula. Details at au.rejuvaus.com/products/repair-refine-abc-serum
For anyone building or reviewing a skincare routine, the questions worth asking are not just which actives are present, but at what concentration, in what delivery format, and whether those two factors together make the dose clinically relevant.
Mathew Hicks is a world-renowned author and expert in the field of business and finance. He has written multiple books and articles on the subject and has been featured in numerous publications. His expertise has been sought by leading financial institutions around the world.